Thrombopoietin receptor MPL (TPO-R), a major regulator of megakaryocytopoiesis and platelet formation, is a proto-oncogene whose ligand (TPO) has been recently identified as a novel candidate marker for ovarian cancer diagnosis and is associated with a poor survival [35, 36]. The gene discussed is TPO; the disease is ovarian cancer.